StephenDwightHarrisonMD

PubMed

• 85 citations
  Therapeutic applications of cell-penetrating peptides.
  Randolph M. Johnson, Stephen D. Harrison, Derek Maclean> ;Methods in Molecular Biology. 2011 Jan 1
• 83 citations
  Glycogen synthase kinase 3β inhibitor Chir025 reduces neuronal death resulting from oxygen-glucose deprivation, glutamate excitotoxicity and cerebral ischemia
  Stephen Kelly, Heng Zhao, Guohua Sun, Danye Cheng, Yanli Qiao, Jian Luo, Kathleen A. Martin, Gary K. Steinberg, Stephen D. Harrison, Midori A. Yenari> ;Experimental Neurology. 2004 Aug 1
• 85 citations
  Modulation of muscle insulin resistance by selective inhibition of GSK-3 in Zucker diabetic fatty rats.
  Erik J. Henriksen, Tyson R. Kinnick, Mary K. Teachey, Matthew P. O'Keefe, David B. Ring, Kirk W. Johnson, Stephen D. Harrison> ;American Journal of Physiology. Endocrinology and Metabolism. 2003 May 1
• 366 citations
  Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo.
  David B. Ring, Kirk W. Johnson, Erik J. Henriksen, John M. Nuss, Dane Goff, Tyson R. Kinnick, Sylvia Ma, John W. Reeder, Isa Samuels, Trina Slabiak, Allan S. Wagman, M...> ;Diabetes. 2003 Mar 1
• 514 citations
  Regulation of Wnt signaling during adipogenesis.
  Christina N. Bennett, Sarah E. Ross, Kenneth A. Longo, Laszlo Bajnok, Nahid Hemati, Kirk Johnson, Stephen D. Harrison, Ormond A. MacDougald> ;The Journal of Biological Chemistry. 2002 Aug 23
• Join now to see all